| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Frattaroli Joseph is a Chief Financial Officer at Inhibikase Therapeutics, Inc.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $99K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | IKT Inhibikase Therapeutics, Inc. | Chief Financial Officer | Buy | 3,948 | $0.64 | $2,542.51 | +8.9% | +30.6% | +1.6% |